Search ⌘K
Tipsheet
An editorial reading of India’s listed companies.
Brief /Earnings / Healthcare IT

Inventurus Q4 PAT jumps 39%, plans TruBridge buy

Revenue up 18.5% YoY with EBITDA margin at 35% as the company rolls out AI products and acquires a physician-services team.


39% PAT growth YoY in Q4 FY2026

What's new

  • Revenue grew 18.5% YoY, EBITDA margin at 35%, PAT up 39%.
  • Planned TruBridge acquisition to boost revenue cycle management.
  • Launched AI offerings: Scribble Select (scribe) and MyCare Hub (patient engagement).

Why it matters

A 39% PAT jump on 35% EBITDA margins shows Inventurus is executing well. The TruBridge acquisition and AI push signal a bet on scale and product-led growth. The test is whether these moves sustain margins while expanding revenue.

What we're watching

  • TruBridge deal timeline and integration costs.
  • Adoption of Scribble Select and MyCare Hub among current clients.
  • Whether EBITDA margins hold above 35% in FY27.

The full read

Inventurus Knowledge Solutions closed Q4 FY2026 with revenue up 18.5% YoY, EBITDA margin at 35%, and PAT rising 39%—a strong finish to the year. The earnings call transcript, however, was less about the numbers and more about what comes next. The company announced plans to acquire TruBridge, a revenue-cycle management firm, launched two AI products (Scribble Select for clinical scribing and MyCare Hub for patient engagement), and completed an acqui-hire of the ARAI team to deepen physician services. Together, these moves suggest Inventurus is building a broader platform play in healthcare IT rather than remaining a pure-services shop. The immediate question is whether the acquisition will be accretive and how quickly the AI tools can gain traction. Margins are high, but sustaining them through a deal cycle will be the real test.

Mentioned: TruBridge · Scribble Select · MyCare Hub
Primary source BSE filings for IKS NSE filings for IKS Research IKS on Tijori Finance Our reading is derived from the exchange filing. Verify on the exchange before acting.